Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,737
Total Claims
$2.4M
Drug Cost
789
Beneficiaries
$3,073
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+85%
Opioid rate vs peers
4.8% vs 2.6% avg
+188%
Cost per patient vs peers
$3,073 vs $1,068 avg
+126%
Brand preference vs peers
20.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.8%
Opioid Rate
940
Opioid Claims
$66K
Opioid Cost
25.7%
Long-Acting Rate
Brand vs Generic
Brand: 3,984 claims · $2.1M
Generic: 15,614 claims · $305K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 490 | $314K |
| Rivaroxaban | 189 | $112K |
| Semaglutide | 106 | $108K |
| Cariprazine Hcl | 61 | $92K |
| Mirabegron | 178 | $88K |
| Semaglutide | 77 | $78K |
| Dulaglutide | 54 | $61K |
| Fluticasone/Umeclidin/Vilanter | 86 | $61K |
| Sitagliptin Phosphate | 89 | $59K |
| Dapagliflozin Propanediol | 82 | $58K |
| Vibegron | 116 | $57K |
| Tiotropium Bromide | 91 | $52K |
| Empagliflozin | 66 | $44K |
| Linaclotide | 65 | $36K |
| Tirzepatide | 30 | $33K |
Prescribing Profile
Patient Profile
73
Avg Age
60%
Female
0.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About